The state of New York’s Department of Financial Services has filed charges against Johnson & Johnson, claiming the drugmaker committed insurance fraud by mischaracterizing its opioid products.
The charges announced Thursday are the fourth set the state has filed against opioid manufacturers, according to a news release. DFS is seeking to recover $5,000 plus the amount of the claim per each fraudulent insurance claim submitted.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.